APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tyrosine Protein Kinase ITK

Compare research editions
View pricing & licenses

Selected research

Industry Research

Tyrosine Protein Kinase ITK Industry Research Report 2026

19 December 2025119 pages

Choose your research edition.

Industry ResearchTyrosine Protein Kinase ITK Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Tyrosine Protein Kinase ITK Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Tyrosine Protein Kinase ITK Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tyrosine Protein Kinase ITK Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Tyrosine Protein Kinase ITK Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Tyrosine Protein Kinase ITK market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Tyrosine Protein Kinase ITK is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Tyrosine Protein Kinase ITK is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Tyrosine Protein Kinase ITK is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Tyrosine Protein Kinase ITK include Novartis AG, Genentech Inc, Principia Biopharma Inc, Japan Tobacco Inc, Corvus Pharmaceuticals Inc, Confluence Life Sciences Inc and Arrien Pharmaceuticals LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Tyrosine Protein Kinase ITK market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Tyrosine Protein Kinase ITK Market by Company

Novartis AG

Genentech Inc

Principia Biopharma Inc

Japan Tobacco Inc

Corvus Pharmaceuticals Inc

Confluence Life Sciences Inc

Arrien Pharmaceuticals LLC

Tyrosine Protein Kinase ITK Segment by Type

ARN-4079

GNE-4997

JTE-051

Pazopanib Hydrochloride

Others

Tyrosine Protein Kinase ITK Segment by Application

Metastatic Renal Cell Carcinoma

Asthma

Chondrosarcoma

Glioblastoma

Others

Tyrosine Protein Kinase ITK Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tyrosine Protein Kinase ITK market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tyrosine Protein Kinase ITK and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tyrosine Protein Kinase ITK.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Tyrosine Protein Kinase ITK manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Tyrosine Protein Kinase ITK by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Tyrosine Protein Kinase ITK in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Tyrosine Protein Kinase ITK Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Tyrosine Protein Kinase ITK Sales (W Units) of Manufacturers (2021-2026) Table 7. Global Tyrosine Protein Kinase ITK Sales Market Share by Manufacturers (2021-2026) Table 8. Global Tyrosine Protein Kinase ITK Revenue of Manufacturers (2021-2026) Table 9. Global Tyrosine Protein Kinase ITK Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Tyrosine Protein Kinase ITK Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Tyrosine Protein Kinase ITK Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Tyrosine Protein Kinase ITK, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Tyrosine Protein Kinase ITK, Product Type & Application Table 14. Global Tyrosine Protein Kinase ITK Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Tyrosine Protein Kinase ITK by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Novartis AG Company Information Table 19. Novartis AG Business Overview Table 20. Novartis AG Tyrosine Protein Kinase ITK Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Novartis AG Tyrosine Protein Kinase ITK Product Portfolio Table 22. Novartis AG Recent Developments Table 23. Genentech Inc Company Information Table 24. Genentech Inc Business Overview Table 25. Genentech Inc Tyrosine Protein Kinase ITK Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Genentech Inc Tyrosine Protein Kinase ITK Product Portfolio Table 27. Genentech Inc Recent Developments Table 28. Principia Biopharma Inc Company Information Table 29. Principia Biopharma Inc Business Overview Table 30. Principia Biopharma Inc Tyrosine Protein Kinase ITK Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Principia Biopharma Inc Tyrosine Protein Kinase ITK Product Portfolio Table 32. Principia Biopharma Inc Recent Developments Table 33. Japan Tobacco Inc Company Information Table 34. Japan Tobacco Inc Business Overview Table 35. Japan Tobacco Inc Tyrosine Protein Kinase ITK Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Japan Tobacco Inc Tyrosine Protein Kinase ITK Product Portfolio Table 37. Japan Tobacco Inc Recent Developments Table 38. Corvus Pharmaceuticals Inc Company Information Table 39. Corvus Pharmaceuticals Inc Business Overview Table 40. Corvus Pharmaceuticals Inc Tyrosine Protein Kinase ITK Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Corvus Pharmaceuticals Inc Tyrosine Protein Kinase ITK Product Portfolio Table 42. Corvus Pharmaceuticals Inc Recent Developments Table 43. Confluence Life Sciences Inc Company Information Table 44. Confluence Life Sciences Inc Business Overview Table 45. Confluence Life Sciences Inc Tyrosine Protein Kinase ITK Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Confluence Life Sciences Inc Tyrosine Protein Kinase ITK Product Portfolio Table 47. Confluence Life Sciences Inc Recent Developments Table 48. Arrien Pharmaceuticals LLC Company Information Table 49. Arrien Pharmaceuticals LLC Business Overview Table 50. Arrien Pharmaceuticals LLC Tyrosine Protein Kinase ITK Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Arrien Pharmaceuticals LLC Tyrosine Protein Kinase ITK Product Portfolio Table 52. Arrien Pharmaceuticals LLC Recent Developments Table 53. Global Tyrosine Protein Kinase ITK Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 54. Global Tyrosine Protein Kinase ITK Sales by Region (2021-2026) & (W Units) Table 55. Global Tyrosine Protein Kinase ITK Sales Market Share by Region (2021-2026) Table 56. Global Tyrosine Protein Kinase ITK Sales by Region (2027-2032) & (W Units) Table 57. Global Tyrosine Protein Kinase ITK Sales Market Share by Region (2027-2032) Table 58. Global Tyrosine Protein Kinase ITK Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Tyrosine Protein Kinase ITK Revenue Market Share by Region (2021-2026) Table 60. Global Tyrosine Protein Kinase ITK Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Tyrosine Protein Kinase ITK Revenue Market Share by Region (2027-2032) Table 62. North America Tyrosine Protein Kinase ITK Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. North America Tyrosine Protein Kinase ITK Sales by Country (2021-2026) & (W Units) Table 64. North America Tyrosine Protein Kinase ITK Sales by Country (2027-2032) & (W Units) Table 65. North America Tyrosine Protein Kinase ITK Revenue by Country (2021-2026) & (US$ Million) Table 66. North America Tyrosine Protein Kinase ITK Revenue by Country (2027-2032) & (US$ Million) Table 67. Europe Tyrosine Protein Kinase ITK Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Europe Tyrosine Protein Kinase ITK Sales by Country (2021-2026) & (W Units) Table 69. Europe Tyrosine Protein Kinase ITK Sales by Country (2027-2032) & (W Units) Table 70. Europe Tyrosine Protein Kinase ITK Revenue by Country (2021-2026) & (US$ Million) Table 71. Europe Tyrosine Protein Kinase ITK Revenue by Country (2027-2032) & (US$ Million) Table 72. Asia Pacific Tyrosine Protein Kinase ITK Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Asia Pacific Tyrosine Protein Kinase ITK Sales by Country (2021-2026) & (W Units) Table 74. Asia Pacific Tyrosine Protein Kinase ITK Sales by Country (2027-2032) & (W Units) Table 75. Asia Pacific Tyrosine Protein Kinase ITK Revenue by Country (2021-2026) & (US$ Million) Table 76. Asia Pacific Tyrosine Protein Kinase ITK Revenue by Country (2027-2032) & (US$ Million) Table 77. South America Tyrosine Protein Kinase ITK Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. South America Tyrosine Protein Kinase ITK Sales by Country (2021-2026) & (W Units) Table 79. South America Tyrosine Protein Kinase ITK Sales by Country (2027-2032) & (W Units) Table 80. South America Tyrosine Protein Kinase ITK Revenue by Country (2021-2026) & (US$ Million) Table 81. South America Tyrosine Protein Kinase ITK Revenue by Country (2027-2032) & (US$ Million) Table 82. Middle East and Africa Tyrosine Protein Kinase ITK Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Middle East and Africa Tyrosine Protein Kinase ITK Sales by Country (2021-2026) & (W Units) Table 84. Middle East and Africa Tyrosine Protein Kinase ITK Sales by Country (2027-2032) & (W Units) Table 85. Middle East and Africa Tyrosine Protein Kinase ITK Revenue by Country (2021-2026) & (US$ Million) Table 86. Middle East and Africa Tyrosine Protein Kinase ITK Revenue by Country (2027-2032) & (US$ Million) Table 87. Global Tyrosine Protein Kinase ITK Sales by Type (2021-2026) & (W Units) Table 88. Global Tyrosine Protein Kinase ITK Sales by Type (2027-2032) & (W Units) Table 89. Global Tyrosine Protein Kinase ITK Sales Market Share by Type (2021-2026) Table 90. Global Tyrosine Protein Kinase ITK Sales Market Share by Type (2027-2032) Table 91. Global Tyrosine Protein Kinase ITK Revenue by Type (2021-2026) & (US$ Million) Table 92. Global Tyrosine Protein Kinase ITK Revenue by Type (2027-2032) & (US$ Million) Table 93. Global Tyrosine Protein Kinase ITK Revenue Market Share by Type (2021-2026) Table 94. Global Tyrosine Protein Kinase ITK Revenue Market Share by Type (2027-2032) Table 95. Global Tyrosine Protein Kinase ITK Price by Type (2021-2026) & (US$/Unit) Table 96. Global Tyrosine Protein Kinase ITK Price by Type (2027-2032) & (US$/Unit) Table 97. Global Tyrosine Protein Kinase ITK Sales by Application (2021-2026) & (W Units) Table 98. Global Tyrosine Protein Kinase ITK Sales by Application (2027-2032) & (W Units) Table 99. Global Tyrosine Protein Kinase ITK Sales Market Share by Application (2021-2026) Table 100. Global Tyrosine Protein Kinase ITK Sales Market Share by Application (2027-2032) Table 101. Global Tyrosine Protein Kinase ITK Revenue by Application (2021-2026) & (US$ Million) Table 102. Global Tyrosine Protein Kinase ITK Revenue by Application (2027-2032) & (US$ Million) Table 103. Global Tyrosine Protein Kinase ITK Revenue Market Share by Application (2021-2026) Table 104. Global Tyrosine Protein Kinase ITK Revenue Market Share by Application (2027-2032) Table 105. Global Tyrosine Protein Kinase ITK Price by Application (2021-2026) & (US$/Unit) Table 106. Global Tyrosine Protein Kinase ITK Price by Application (2027-2032) & (US$/Unit) Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Tyrosine Protein Kinase ITK Distributors List Table 110. Tyrosine Protein Kinase ITK Customers List Table 111. Tyrosine Protein Kinase ITK Industry Trends Table 112. Tyrosine Protein Kinase ITK Industry Drivers Table 113. Tyrosine Protein Kinase ITK Industry Restraints Table 114. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Tyrosine Protein Kinase ITK Product Image Figure 5. Global Tyrosine Protein Kinase ITK Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Tyrosine Protein Kinase ITK Market Size (2021-2032) & (US$ Million) Figure 7. Global Tyrosine Protein Kinase ITK Sales (2021-2032) & (W Units) Figure 8. Global Tyrosine Protein Kinase ITK Average Price (US$/Unit) & (2021-2032) Figure 9. ARN-4079 Product Image Figure 10. GNE-4997 Product Image Figure 11. JTE-051 Product Image Figure 12. Pazopanib Hydrochloride Product Image Figure 13. Others Product Image Figure 14. Metastatic Renal Cell Carcinoma Product Image Figure 15. Asthma Product Image Figure 16. Chondrosarcoma Product Image Figure 17. Glioblastoma Product Image Figure 18. Others Product Image Figure 19. Global Tyrosine Protein Kinase ITK Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Tyrosine Protein Kinase ITK, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Tyrosine Protein Kinase ITK Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Tyrosine Protein Kinase ITK Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Tyrosine Protein Kinase ITK Sales by Region in 2025 Figure 25. Global Tyrosine Protein Kinase ITK Revenue by Region in 2025 Figure 26. North America Tyrosine Protein Kinase ITK Market Size by Country in 2025 Figure 27. North America Tyrosine Protein Kinase ITK Sales Market Share by Country (2021-2032) Figure 28. North America Tyrosine Protein Kinase ITK Revenue Market Share by Country (2021-2032) Figure 29. United States Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Tyrosine Protein Kinase ITK Market Size by Country in 2025 Figure 32. Europe Tyrosine Protein Kinase ITK Sales Market Share by Country (2021-2032) Figure 33. Europe Tyrosine Protein Kinase ITK Revenue Market Share by Country (2021-2032) Figure 34. Germany Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Nordic Countries Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Tyrosine Protein Kinase ITK Market Size by Country in 2025 Figure 41. Asia Pacific Tyrosine Protein Kinase ITK Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Tyrosine Protein Kinase ITK Revenue Market Share by Country (2021-2032) Figure 43. China Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. China Taiwan Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Tyrosine Protein Kinase ITK Market Size by Country in 2025 Figure 52. South America Tyrosine Protein Kinase ITK Sales Market Share by Country (2021-2032) Figure 53. South America Tyrosine Protein Kinase ITK Revenue Market Share by Country (2021-2032) Figure 54. Mexico Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Brazil Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Tyrosine Protein Kinase ITK Market Size by Country in 2025 Figure 59. Middle East and Africa Tyrosine Protein Kinase ITK Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Tyrosine Protein Kinase ITK Revenue Market Share by Country (2021-2032) Figure 61. Turkey Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. UAE Tyrosine Protein Kinase ITK Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Tyrosine Protein Kinase ITK Sales Market Share by Type (2021-2032) Figure 65. Global Tyrosine Protein Kinase ITK Revenue Market Share by Type (2021-2032) Figure 66. Global Tyrosine Protein Kinase ITK Price (US$/Unit) by Type (2021-2032) Figure 67. Global Tyrosine Protein Kinase ITK Sales Market Share by Application (2021-2032) Figure 68. Global Tyrosine Protein Kinase ITK Revenue Market Share by Application (2021-2032) Figure 69. Global Tyrosine Protein Kinase ITK Price (US$/Unit) by Application (2021-2032) Figure 70. Tyrosine Protein Kinase ITK Value Chain Figure 71. Tyrosine Protein Kinase ITK Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Tyrosine Protein Kinase ITK Industry Opportunities and Challenges

Scope & coverage.

Types
  • ARN-4079
  • GNE-4997
  • JTE-051
  • Pazopanib Hydrochloride
  • Others
Applications
  • Metastatic Renal Cell Carcinoma
  • Asthma
  • Chondrosarcoma
  • Glioblastoma
  • Others
Companies covered
  • Novartis AG
  • Genentech Inc
  • Principia Biopharma Inc
  • Japan Tobacco Inc
  • Corvus Pharmaceuticals Inc
  • Confluence Life Sciences Inc
  • Arrien Pharmaceuticals LLC

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Tyrosine Protein Kinase ITK Market Size (2021-2032)
  4. 2.2.2 Global Tyrosine Protein Kinase ITK Sales (2021-2032)
  5. 2.2.3 Global Tyrosine Protein Kinase ITK Market Average Price (2021-2032)
  6. 2.3 Tyrosine Protein Kinase ITK by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 ARN-4079
  9. 2.3.3 GNE-4997
  10. 2.3.4 JTE-051
  11. 2.3.5 Pazopanib Hydrochloride
  12. 2.3.6 Others
  13. 2.4 Tyrosine Protein Kinase ITK by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Metastatic Renal Cell Carcinoma
  16. 2.4.3 Asthma
  17. 2.4.4 Chondrosarcoma
  18. 2.4.5 Glioblastoma
  19. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Tyrosine Protein Kinase ITK Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Tyrosine Protein Kinase ITK Sales (W Units) of Manufacturers (2021-2026)
  3. 3.3 Global Tyrosine Protein Kinase ITK Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Tyrosine Protein Kinase ITK Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Tyrosine Protein Kinase ITK Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Tyrosine Protein Kinase ITK, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Tyrosine Protein Kinase ITK, Product Type & Application
  8. 3.8 Global Manufacturers of Tyrosine Protein Kinase ITK, Established Date
  9. 3.9 Global Tyrosine Protein Kinase ITK Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Novartis AG
  2. 4.1.1 Novartis AG Company Information
  3. 4.1.2 Novartis AG Business Overview
  4. 4.1.3 Novartis AG Tyrosine Protein Kinase ITK Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Novartis AG Tyrosine Protein Kinase ITK Product Portfolio
  6. 4.1.5 Novartis AG Recent Developments
  7. 4.2 Genentech Inc
  8. 4.2.1 Genentech Inc Company Information
  9. 4.2.2 Genentech Inc Business Overview
  10. 4.2.3 Genentech Inc Tyrosine Protein Kinase ITK Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Genentech Inc Tyrosine Protein Kinase ITK Product Portfolio
  12. 4.2.5 Genentech Inc Recent Developments
  13. 4.3 Principia Biopharma Inc
  14. 4.3.1 Principia Biopharma Inc Company Information
  15. 4.3.2 Principia Biopharma Inc Business Overview
  16. 4.3.3 Principia Biopharma Inc Tyrosine Protein Kinase ITK Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Principia Biopharma Inc Tyrosine Protein Kinase ITK Product Portfolio
  18. 4.3.5 Principia Biopharma Inc Recent Developments
  19. 4.4 Japan Tobacco Inc
  20. 4.4.1 Japan Tobacco Inc Company Information
  21. 4.4.2 Japan Tobacco Inc Business Overview
  22. 4.4.3 Japan Tobacco Inc Tyrosine Protein Kinase ITK Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Japan Tobacco Inc Tyrosine Protein Kinase ITK Product Portfolio
  24. 4.4.5 Japan Tobacco Inc Recent Developments
  25. 4.5 Corvus Pharmaceuticals Inc
  26. 4.5.1 Corvus Pharmaceuticals Inc Company Information
  27. 4.5.2 Corvus Pharmaceuticals Inc Business Overview
  28. 4.5.3 Corvus Pharmaceuticals Inc Tyrosine Protein Kinase ITK Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Corvus Pharmaceuticals Inc Tyrosine Protein Kinase ITK Product Portfolio
  30. 4.5.5 Corvus Pharmaceuticals Inc Recent Developments
  31. 4.6 Confluence Life Sciences Inc
  32. 4.6.1 Confluence Life Sciences Inc Company Information
  33. 4.6.2 Confluence Life Sciences Inc Business Overview
  34. 4.6.3 Confluence Life Sciences Inc Tyrosine Protein Kinase ITK Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Confluence Life Sciences Inc Tyrosine Protein Kinase ITK Product Portfolio
  36. 4.6.5 Confluence Life Sciences Inc Recent Developments
  37. 4.7 Arrien Pharmaceuticals LLC
  38. 4.7.1 Arrien Pharmaceuticals LLC Company Information
  39. 4.7.2 Arrien Pharmaceuticals LLC Business Overview
  40. 4.7.3 Arrien Pharmaceuticals LLC Tyrosine Protein Kinase ITK Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Arrien Pharmaceuticals LLC Tyrosine Protein Kinase ITK Product Portfolio
  42. 4.7.5 Arrien Pharmaceuticals LLC Recent Developments
5 Global Tyrosine Protein Kinase ITK Market Scenario by Region
  1. 5.1 Global Tyrosine Protein Kinase ITK Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Tyrosine Protein Kinase ITK Sales by Region: 2021-2032
  3. 5.2.1 Global Tyrosine Protein Kinase ITK Sales by Region: 2021-2026
  4. 5.2.2 Global Tyrosine Protein Kinase ITK Sales by Region: 2027-2032
  5. 5.3 Global Tyrosine Protein Kinase ITK Revenue by Region: 2021-2032
  6. 5.3.1 Global Tyrosine Protein Kinase ITK Revenue by Region: 2021-2026
  7. 5.3.2 Global Tyrosine Protein Kinase ITK Revenue by Region: 2027-2032
  8. 5.4 North America Tyrosine Protein Kinase ITK Market Facts & Figures by Country
  9. 5.4.1 North America Tyrosine Protein Kinase ITK Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Tyrosine Protein Kinase ITK Sales by Country (2021-2032)
  11. 5.4.3 North America Tyrosine Protein Kinase ITK Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Tyrosine Protein Kinase ITK Market Facts & Figures by Country
  15. 5.5.1 Europe Tyrosine Protein Kinase ITK Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Tyrosine Protein Kinase ITK Sales by Country (2021-2032)
  17. 5.5.3 Europe Tyrosine Protein Kinase ITK Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Tyrosine Protein Kinase ITK Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Tyrosine Protein Kinase ITK Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Tyrosine Protein Kinase ITK Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Tyrosine Protein Kinase ITK Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Tyrosine Protein Kinase ITK Market Facts & Figures by Country
  36. 5.7.1 South America Tyrosine Protein Kinase ITK Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Tyrosine Protein Kinase ITK Sales by Country (2021-2032)
  38. 5.7.3 South America Tyrosine Protein Kinase ITK Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.7.7 Colombia
  43. 5.8 Middle East and Africa Tyrosine Protein Kinase ITK Market Facts & Figures by Country
  44. 5.8.1 Middle East and Africa Tyrosine Protein Kinase ITK Market Size by Country: 2021 VS 2025 VS 2032
  45. 5.8.2 Middle East and Africa Tyrosine Protein Kinase ITK Sales by Country (2021-2032)
  46. 5.8.3 Middle East and Africa Tyrosine Protein Kinase ITK Revenue by Country (2021-2032)
  47. 5.8.4 Turkey
  48. 5.8.5 Saudi Arabia
  49. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Tyrosine Protein Kinase ITK Sales by Type (2021-2032)
  2. 6.1.1 Global Tyrosine Protein Kinase ITK Sales by Type (2021-2032) & (W Units)
  3. 6.1.2 Global Tyrosine Protein Kinase ITK Sales Market Share by Type (2021-2032)
  4. 6.2 Global Tyrosine Protein Kinase ITK Revenue by Type (2021-2032)
  5. 6.2.1 Global Tyrosine Protein Kinase ITK Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Tyrosine Protein Kinase ITK Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Tyrosine Protein Kinase ITK Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Tyrosine Protein Kinase ITK Sales by Application (2021-2032)
  2. 7.1.1 Global Tyrosine Protein Kinase ITK Sales by Application (2021-2032) & (W Units)
  3. 7.1.2 Global Tyrosine Protein Kinase ITK Sales Market Share by Application (2021-2032)
  4. 7.2 Global Tyrosine Protein Kinase ITK Revenue by Application (2021-2032)
  5. 7.2.1 Global Tyrosine Protein Kinase ITK Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Tyrosine Protein Kinase ITK Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Tyrosine Protein Kinase ITK Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Tyrosine Protein Kinase ITK Value Chain Analysis
  2. 8.1.1 Tyrosine Protein Kinase ITK Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Tyrosine Protein Kinase ITK Production Mode & Process
  5. 8.2 Tyrosine Protein Kinase ITK Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Tyrosine Protein Kinase ITK Distributors
  8. 8.2.3 Tyrosine Protein Kinase ITK Customers
9 Global Tyrosine Protein Kinase ITK Analyzing Market Dynamics
  1. 9.1 Tyrosine Protein Kinase ITK Industry Trends
  2. 9.2 Tyrosine Protein Kinase ITK Industry Drivers
  3. 9.3 Tyrosine Protein Kinase ITK Industry Opportunities and Challenges
  4. 9.4 Tyrosine Protein Kinase ITK Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst